Literature DB >> 3300951

The Memorial Pain Assessment Card. A valid instrument for the evaluation of cancer pain.

B Fishman, S Pasternak, S L Wallenstein, R W Houde, J C Holland, K M Foley.   

Abstract

Effective evaluation and treatment of cancer pain require valid and independent measurement of pain intensity, pain relief, and psychological distress. The Memorial Pain Assessment Card (MPAC) is a simple instrument designed to provide rapid evaluation of these subjective experiences. On the 8.5 by 11 inch card are printed the eight pain intensity descriptors, and three visual analog scales which measure pain intensity, pain relief, and mood. Experienced patients can complete it in less than 20 seconds. The authors administered the MPAC to 50 hospitalized cancer patients within 48 hours of referral to the Pain Service for inadequate pain control, together with standard measures: The McGill Pain Questionnaire, Profile of Mood States, Hamilton Depression Scale, and Zung Anxiety Scale. Correlational and multiple regression analyses revealed that the MPAC can distinguish pain intensity from pain relief and from general psychological distress, and it can provide multidimensional assessment that is practically equivalent to the full assessment battery. We conclude that the MPAC is valid and effective for clinical use, and recommend it for the assessment of individual patients, and as an outcome measure in clinical trials.

Entities:  

Mesh:

Year:  1987        PMID: 3300951     DOI: 10.1002/1097-0142(19870901)60:5<1151::aid-cncr2820600538>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  42 in total

1.  [Pain assessment in invasive diagnostic procedures. Comparison of an eleven-point numerical rating scale and a six-point verbal rating scale for pain measurement in bone marrow puncture].

Authors:  M Weber; J Schüz; J Kuball; H Gamm; J Jage
Journal:  Schmerz       Date:  2005-11       Impact factor: 1.107

2.  Massage therapy versus simple touch to improve pain and mood in patients with advanced cancer: a randomized trial.

Authors:  Jean S Kutner; Marlaine C Smith; Lisa Corbin; Linnea Hemphill; Kathryn Benton; B Karen Mellis; Brenda Beaty; Sue Felton; Traci E Yamashita; Lucinda L Bryant; Diane L Fairclough
Journal:  Ann Intern Med       Date:  2008-09-16       Impact factor: 25.391

3.  Cancer pain--progress and ongoing issues in Singapore.

Authors:  Allyn Hum; Angel Lee; Wu Huei Yaw
Journal:  Pain Res Manag       Date:  2009 Sep-Oct       Impact factor: 3.037

4.  Solitary painful osseous metastases: correlation of imaging features with pain palliation after radiofrequency ablation--a multicenter american college of radiology imaging network study.

Authors:  Jeffrey P Guenette; Michael J Lopez; Eunhee Kim; Damian E Dupuy
Journal:  Radiology       Date:  2013-05-08       Impact factor: 11.105

5.  Establishing equivalence between scaled measures of quality of life.

Authors:  R Gonin; S Lloyd; D Cella; G Gray
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

6.  Phase II study of topotecan in metastatic hormone-refractory prostate cancer.

Authors:  G R Hudes; R Kosierowski; R Greenberg; H E Ramsey; S C Fox; R F Ozols; C A McAleer; B J Giantonio
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

Review 7.  Quality of life measures in cancer chemotherapy: methodology and implications.

Authors:  P A Ganz
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

8.  Development of a brief survey to measure nursing home residents' perceptions of pain management.

Authors:  Joan M Teno; David Dosa; Therese Rochon; Virginia Casey; Vincent Mor
Journal:  J Pain Symptom Manage       Date:  2008-06-17       Impact factor: 3.612

9.  Reliability and validity of the Korean Cancer Pain Assessment Tool (KCPAT).

Authors:  Jeong A Kim; Youn Seon Choi; Juneyoung Lee; Jeanno Park; Myung Ah Lee; Chang Hwan Yeom; Se Kwon Jang; Duck Mi Yoon; Jun Suk Kim
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

10.  Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy.

Authors:  J Bernhard; D Dietrich; B Glimelius; V Hess; G Bodoky; W Scheithauer; R Herrmann
Journal:  Br J Cancer       Date:  2010-09-28       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.